Glencore-owned Viterra has failed in its bid for High Court leave to challenge a ruling in a 10-year battle with Cargill over the 2013 sale of malt producer Joe White, leaving the grain producer to fork over damages of almost $300 million.
An investigation is underway against US medical device maker Exactech on behalf of patients who allegedly received faulty hip, knee or ankle implants.
A Tiwi Island traditional owner has brought fresh legal action against Santos, seeking to block the energy giant from building its Barossa gas export pipeline without a proper assessment of the risks to cultural heritage.
The Commissioner of Taxation is pursuing a former Big Four partner for allegedly promoting tax exploitation schemes for clients. But a fight has broken out in court over whether his identity — and the name of the accounting firm — should be suppressed.
Two former Dick Smith executives have settled with the receivers of the defunct electronics retailer, dropping a High Court appeal over an $11.8 million ruling.
The winning, 14 per cent contingency fee proposal by Slater & Gordon in a fight to run a class action against Star Entertainment was not driven by a desire to prevail in the contest and buy market share but was the product of a “reasoned decision” that took into account the law firm’s practice as a whole, a judge has found.
Following the decision of Justice Michael Lee in the Ethicon class actions appointing settlement administrators we published an article entitled ‘Winner of J&J class action settlement gig beats back challenger’.
Holden dealers in a class action over GM’s decision to retire the brand in March 2020 have taken issue with the car maker’s counterfactual in defence, which argues the plant supplying Holden’s best-selling models would have closed anyway.
Independent Sydney MP Alex Greenwich, who is suing politician Mark Latham over a homophobic social media post, claims the One Nation NSW leader’s defence has aggravated his damages by relying on a “disgraceful” gay stereotype.
Infant formula giant Care A2 will try again to block business partner Gensco from bringing claims against it in a US court that overlap with a $200 million Australian lawsuit over a deal to sell formula in the US.